COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer
Clinical trial NCT04038489 · WITHDRAWN
Trial details
- NCT number
- NCT04038489
- Sponsor
- University of Virginia
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2023-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.